1
|
Zhao H, Liu X, Zou H, Dai N, Yao L, Zhang X, Gao Q, Liu W, Gu J, Yuan Y, Bian J, Liu Z. Osteoprotegerin disrupts peripheral adhesive structures of osteoclasts by modulating Pyk2 and Src activities. Cell Adh Migr 2016; 10:299-309. [PMID: 26743491 DOI: 10.1080/19336918.2015.1129480] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Abstract
Osteoprotegerin has previously been shown to modulate bone mass by blocking osteoclast maturation and function. The detailed mechanisms of osteoprotegerin-induced disassembly of podosomes, disruption of adhesive structures and modulation of adhesion-related proteins in osteoclasts, however, are not well characterized. In this study, tartrate-resistant acidic phosphatase staining demonstrated that osteoprotegerin inhibited differentiation of osteoclasts. The use of scanning electron microscopy, real-time cell monitoring and confocal microscopy indicated that osteoclasts responded in a time and dose-dependent manner to osteoprotegerin treatments with retraction of peripheral adhesive structures and detachment from the extracellular substrate. Combined imaging and Western blot studies showed that osteoprotegerin induced dephosphorylation of Tyr 402 in Pyk2 and decreased its labeling in peripheral adhesion regions. osteoprotegerin induced increased intracellular labeling of Tyr 402 in Pyk2, Tyr 416 in Src, increased dephosphorylation of Tyr 527 in Src, and increased Pyk2/Src association in the central region of osteoclasts. This evidence suggests that Src may function as an adaptor protein that competes for Pyk2 and relocates it from the peripheral adhesive zone to the central region of osteoclasts in response to osteoprotegerin treatment. Osteoprotegerin may induce podosome reassembly and peripheral adhesive structure detachment by modulating phosphorylation of Pyk2 and Src and their intracellular distribution in osteoclasts.
Collapse
Affiliation(s)
- Hongyan Zhao
- a College of Veterinary Medicine, Yangzhou University , Yangzhou , Jiangsu , P.R. China.,b Jiangsu Co-innovation Center for Prevention and Control of Important, Animal Infectious Diseases and Zoonoses , Yangzhou , Jiangsu , P.R. China
| | - Xuezhong Liu
- a College of Veterinary Medicine, Yangzhou University , Yangzhou , Jiangsu , P.R. China.,b Jiangsu Co-innovation Center for Prevention and Control of Important, Animal Infectious Diseases and Zoonoses , Yangzhou , Jiangsu , P.R. China
| | - Hui Zou
- a College of Veterinary Medicine, Yangzhou University , Yangzhou , Jiangsu , P.R. China.,b Jiangsu Co-innovation Center for Prevention and Control of Important, Animal Infectious Diseases and Zoonoses , Yangzhou , Jiangsu , P.R. China
| | - Nannan Dai
- a College of Veterinary Medicine, Yangzhou University , Yangzhou , Jiangsu , P.R. China.,b Jiangsu Co-innovation Center for Prevention and Control of Important, Animal Infectious Diseases and Zoonoses , Yangzhou , Jiangsu , P.R. China
| | - Lulian Yao
- a College of Veterinary Medicine, Yangzhou University , Yangzhou , Jiangsu , P.R. China.,b Jiangsu Co-innovation Center for Prevention and Control of Important, Animal Infectious Diseases and Zoonoses , Yangzhou , Jiangsu , P.R. China
| | - Xiao Zhang
- a College of Veterinary Medicine, Yangzhou University , Yangzhou , Jiangsu , P.R. China.,b Jiangsu Co-innovation Center for Prevention and Control of Important, Animal Infectious Diseases and Zoonoses , Yangzhou , Jiangsu , P.R. China
| | - Qian Gao
- a College of Veterinary Medicine, Yangzhou University , Yangzhou , Jiangsu , P.R. China.,b Jiangsu Co-innovation Center for Prevention and Control of Important, Animal Infectious Diseases and Zoonoses , Yangzhou , Jiangsu , P.R. China
| | - Wei Liu
- a College of Veterinary Medicine, Yangzhou University , Yangzhou , Jiangsu , P.R. China.,b Jiangsu Co-innovation Center for Prevention and Control of Important, Animal Infectious Diseases and Zoonoses , Yangzhou , Jiangsu , P.R. China
| | - Jianhong Gu
- a College of Veterinary Medicine, Yangzhou University , Yangzhou , Jiangsu , P.R. China.,b Jiangsu Co-innovation Center for Prevention and Control of Important, Animal Infectious Diseases and Zoonoses , Yangzhou , Jiangsu , P.R. China
| | - Yan Yuan
- a College of Veterinary Medicine, Yangzhou University , Yangzhou , Jiangsu , P.R. China.,b Jiangsu Co-innovation Center for Prevention and Control of Important, Animal Infectious Diseases and Zoonoses , Yangzhou , Jiangsu , P.R. China
| | - Jianchun Bian
- a College of Veterinary Medicine, Yangzhou University , Yangzhou , Jiangsu , P.R. China.,b Jiangsu Co-innovation Center for Prevention and Control of Important, Animal Infectious Diseases and Zoonoses , Yangzhou , Jiangsu , P.R. China
| | - Zongping Liu
- a College of Veterinary Medicine, Yangzhou University , Yangzhou , Jiangsu , P.R. China.,b Jiangsu Co-innovation Center for Prevention and Control of Important, Animal Infectious Diseases and Zoonoses , Yangzhou , Jiangsu , P.R. China
| |
Collapse
|
3
|
Lee JH, Chun KJ, Kim HS, Kim SH, Lee KY, Kim DJ, Lim D. Changes in microarchitectural characteristics at the tibial epiphysis induced by collagen-induced rheumatoid arthritis over time. Clin Interv Aging 2012; 7:373-82. [PMID: 23049249 PMCID: PMC3459572 DOI: 10.2147/cia.s35202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Background Little is known about the time course of changes in the microarchitecture of the tibial epiphysis with rheumatoid arthritis (RA), although such information would be valuable in predicting risk of fracture. Therefore, we used in vivo microcomputed tomography (μ-CT) to assess patterns of microarchitectural alterations in the tibial epiphysis using collagen-induced RA in an animal model. Methods Bovine type II collagen was injected intradermally into the tails of rats for induction of RA. The tibial joints were scanned by in vivo μ-CT at 0, 4, and 8 weeks following injection. Microarchitectural parameters were measured to evaluate alteration patterns of bone microarchitecture at the tibial epiphysis. Results The microarchitectural alterations in an RA group were significantly different from those in a control group from 0 to 4 weeks and from 4 to 8 weeks following injection (P < 0.05). The distribution of trabecular bone thickness and trabecular bone separation from 0 weeks to 8 weeks differed significantly (P < 0.05). Conclusion These results indicate that the patterns of microarchitectural alterations at the tibial epiphysis are strongly affected by collagen-induced progression of RA and entail a severe risk of fracture at the tibial epiphysis. This study represents a valuable first approach to tracking periodic and continuous changes in the microarchitectural characteristics of the tibial epiphysis with collagen-induced RA.
Collapse
Affiliation(s)
- Joo Hyung Lee
- Department of Mechanical Engineering, Sejong University, Seoul, Republic of Korea
| | | | | | | | | | | | | |
Collapse
|
4
|
Influence of bisphosphonate treatment on medullary macrophages and osteoclasts: an experimental study. BONE MARROW RESEARCH 2012; 2012:526236. [PMID: 23008775 PMCID: PMC3449103 DOI: 10.1155/2012/526236] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/31/2012] [Revised: 08/03/2012] [Accepted: 08/04/2012] [Indexed: 12/31/2022]
Abstract
Nitrogen-containing bisphosphonates are widely used for treating diverse bone pathologies. They are anticatabolic drugs that act on osteoclasts inhibiting bone resorption. It remains unknown whether the mechanism of action is by decreasing osteoclast number, impairing osteoclast function, or whether they continue to effectively inhibit bone resorption despite the increase in osteoclast number. There is increasing evidence that bisphosphonates also act on bone marrow cells like macrophages and monocytes. The present work sought to evaluate the dynamics of preosteoclast fusion and possible changes in medullary macrophage number in bisphosphonate-treated animals. Healthy female Wistar rats received olpadronate, alendronate, or vehicle during 5 weeks, and 5-bromo-2-deoxyuridine (BrdU) on day 7, 28, or 34 of the experiment. Histomorphometric studies were performed to study femurs and evaluate: number of nuclei per osteoclast (N.Nu/Oc); number of BrdU-positive nuclei (N.Nu BrdU+/Oc); percentage of BrdU-positive nuclei per osteoclast (%Nu.BrdU+/Oc); medullary macrophage number (mac/mm2) and correlation between N.Nu/Oc and mac/mm2. Results showed bisphosphonate-treated animals exhibited increased N.Nu/Oc, caused by an increase in preosteoclast fusion rate and evidenced by higher N.Nu BrdU+/Oc, and significantly decreased mac/mm2. Considering the common origin of osteoclasts and macrophages, the increased demand for precursors of the osteoclast lineage may occur at the expense of macrophage lineage precursors.
Collapse
|
5
|
Penolazzi L, Lampronti I, Borgatti M, Khan MTH, Zennaro M, Piva R, Gambari R. Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE 2008; 8:59. [PMID: 18973662 PMCID: PMC2587459 DOI: 10.1186/1472-6882-8-59] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/20/2008] [Accepted: 10/30/2008] [Indexed: 12/19/2022]
Abstract
Background Osteoclasts (OCs) are involved in rheumatoid arthritis and in several pathologies associated with bone loss. Recent results support the concept that some medicinal plants and derived natural products are of great interest for developing therapeutic strategies against bone disorders, including rheumatoid arthritis and osteoporosis. In this study we determined whether extracts of Emblica officinalis fruits display activity of possible interest for the treatment of rheumatoid arthritis and osteoporosis by activating programmed cell death of human primary osteoclasts. Methods The effects of extracts from Emblica officinalis on differentiation and survival of human primary OCs cultures obtained from peripheral blood were determined by tartrate-acid resistant acid phosphatase (TRAP)-positivity and colorimetric MTT assay. The effects of Emblica officinalis extracts on induction of OCs apoptosis were studied using TUNEL and immunocytochemical analysis of FAS receptor expression. Finally, in vitro effects of Emblica officinalis extracts on NF-kB transcription factor activity were determined by gel shift experiments. Results Extracts of Emblica officinalis were able to induce programmed cell death of mature OCs, without altering, at the concentrations employed in our study, the process of osteoclastogenesis. Emblica officinalis increased the expression levels of Fas, a critical member of the apoptotic pathway. Gel shift experiments demonstrated that Emblica officinalis extracts act by interfering with NF-kB activity, a transcription factor involved in osteoclast biology. The data obtained demonstrate that Emblica officinalis extracts selectively compete with the binding of transcription factor NF-kB to its specific target DNA sequences. This effect might explain the observed effects of Emblica officinalis on the expression levels of interleukin-6, a NF-kB specific target gene. Conclusion Induction of apoptosis of osteoclasts could be an important strategy both in interfering with rheumatoid arthritis complications of the bone skeleton leading to joint destruction, and preventing and reducing osteoporosis. Accordingly, we suggest the application of Emblica officinalis extracts as an alternative tool for therapy applied to bone diseases.
Collapse
|
6
|
Wei S, Siegal GP. Mechanisms modulating inflammatory osteolysis: a review with insights into therapeutic targets. Pathol Res Pract 2008; 204:695-706. [PMID: 18757139 DOI: 10.1016/j.prp.2008.07.002] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/05/2007] [Revised: 05/02/2008] [Accepted: 07/09/2008] [Indexed: 01/22/2023]
Abstract
Inflammatory osteolysis is a relatively frequent and incapacitating complication of rheumatoid arthritis and multiple other inflammation-associated bone diseases. It is thought to operate through an ultimate common pathway of accelerated osteoclast recruitment and activation under the control of cytokines produced in the inflammatory environment. Over the past decade, there have been major advances in our understanding of the mechanisms of osteoclastogenesis. It is now clear that the interaction of receptor activator NF-kappaB (RANK) and its ligand, RANKL, plays a central role in osteoclast formation and activity. Therefore, understanding osteoclastogenesis offers new pathways for potential therapeutic intervention in inflammatory osteolysis. The success of anti-tumor necrosis factor-alpha and interleukin-1 therapy highlights the central role that these specific cytokines play in this disease. This review outlines our current understanding of the mechanisms mediating inflammatory osteolysis and highlights potential therapeutic strategies.
Collapse
Affiliation(s)
- Shi Wei
- Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35223, USA
| | | |
Collapse
|
7
|
Hu Y, Ek-Rylander B, Karlström E, Wendel M, Andersson G. Osteoclast size heterogeneity in rat long bones is associated with differences in adhesive ligand specificity. Exp Cell Res 2007; 314:638-50. [PMID: 18086469 DOI: 10.1016/j.yexcr.2007.11.008] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2007] [Revised: 11/09/2007] [Accepted: 11/12/2007] [Indexed: 01/15/2023]
Abstract
Prothrombin (PT) is an RGD-containing bone-residing precursor to the serine protease thrombin (TH), which acts as an agonist for a variety of cellular responses in osteoblasts and osteoclasts. We show here that PT, TH, osteopontin (OPN) and fibronectin (FN) promoted adhesion of isolated neonatal rat long bone osteoclasts. However, the cells that adhered to PT and TH were smaller in size, rounded and contained 3-4 nuclei, in comparison to the cells adhering to OPN and FN, which were larger with extended cytoplasmic processes and 6-7 nuclei. Attachment of the larger osteoclasts to OPN and FN was inhibited by antibodies towards beta 3 and beta 1 integrin subunits, respectively. Whereas an RGD-containing peptide inhibited adhesion of the smaller osteoclasts to PT and TH, this was not seen with the beta 3 or beta 1 antibodies. In contrast, the beta 1 antibody augmented osteoclast adhesion to PT and TH in an RGD-dependent manner. Small osteoclasts were less efficient in resorbing mineralized bovine bone slices, as well as expressed lower mRNA levels of MMP-9 and the cathepsins K and L compared to large osteoclasts. The small osteoclast adhering to PT and TH may represent either an immature, less functional precursor to the large osteoclast or alternatively constitute a distinct osteoclast population with a specific role in bone.
Collapse
Affiliation(s)
- Yingwei Hu
- Center for Oral Biology, Department of Odontology, Karolinska Institutet, SE-141 04 Huddinge, Sweden
| | | | | | | | | |
Collapse
|